Gilead’s COVID-19 drug Veklury falls short in WHO’s global trialGilead’s Veklury (remdesivir) has failed to produce an effect on hospital stay and mortality in COVID-19 patients in Share XGilead’s COVID-19 drug Veklury falls short in WHO’s global trialhttps://pharmaphorum.com/news/gileads-covid-19-drug-veklury-falls-short-in-whos-global-trial/
EU ramps up supply of COVID-19 vaccine, drugsThe European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after Share XEU ramps up supply of COVID-19 vaccine, drugshttps://pharmaphorum.com/news/eu-ramps-up-supply-of-covid-19-vaccine-drugs/
Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapyAdding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients Share XTrial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapyhttps://pharmaphorum.com/news/trial-backs-lillys-olumiant-plus-remdesivir-as-combo-covid-19-therapy/
Gilead files COVID-19 drug remdesivir with FDAGilead has filed its COVID-19 drug remdesivir with the FDA, to treat patients with severe disease, under the Share XGilead files COVID-19 drug remdesivir with FDAhttps://pharmaphorum.com/news/gilead-files-covid-19-drug-remdesivir-with-fda/
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivirPfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is Share XPfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivirhttps://pharmaphorum.com/news/pfizer-signs-deal-with-gilead-to-manufacture-covid-19-antiviral-remdesivir/
Gilead finds survival boost with remdesivir with unorthodox analysisGilead says an analysis of clinical trial and retrospective real-world data suggest remdesivir can improve survival in severe Share XGilead finds survival boost with remdesivir with unorthodox analysishttps://pharmaphorum.com/news/gilead-finds-survival-boost-with-remdesivir-with-unorthodox-analysis/
Gilead starts trials of inhaled remdesivir for earlier-stage COVID-19The first healthy volunteers have started to receive doses of Gilead’s inhaled formulation of remdesivir, which it hopes Share XGilead starts trials of inhaled remdesivir for earlier-stage COVID-19https://pharmaphorum.com/news/gilead-starts-trials-of-inhaled-remdesivir-for-earlier-stage-covid-19/
European Commission approves Gilead’s remdesivir for COVID-19The European Commission has conditionally approved Gilead’s remdesivir for treatment of COVID-19, the first drug officially cleared for use against Share XEuropean Commission approves Gilead’s remdesivir for COVID-19https://pharmaphorum.com/news/european-commission-approves-gileads-remdesivir-for-covid-19/
US government buys most of world’s supply of COVID-19 drug remdesivirThe US government has acquired most of the global supply of Gilead’s COVID-19 drug remdesivir until September as Share XUS government buys most of world’s supply of COVID-19 drug remdesivirhttps://pharmaphorum.com/news/us-government-buys-most-of-worlds-supply-of-covid-19-drug-remdesivir/
